(Q46045302)

19 December 2017

title

GPER-1 expression decreases during breast cancer tumorigenesis (English)

1 reference

19 December 2017

5

Andrzej Semczuk

1 reference

19 December 2017

author name string

Tanja Ignatov

1

1 reference

19 December 2017

Christine Weißenborn

2

1 reference

19 December 2017

Angela Poehlmann

3

1 reference

19 December 2017

Antje Lemke

4

1 reference

19 December 2017

Albert Roessner

6

1 reference

19 December 2017

Serban Dan Costa

7

1 reference

19 December 2017

Thomas Kalinski

8

1 reference

19 December 2017

Atanas Ignatov

9

1 reference

19 December 2017

publication date

1 June 2013

1 reference

19 December 2017

published in

Cancer Investigation

1 reference

19 December 2017

volume

31

1 reference

19 December 2017

issue

5

1 reference

19 December 2017

page(s)

309-315

1 reference

19 December 2017

Steroid hormone receptors: an update

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.789901

What does an orphan G-protein-coupled receptor have to do with estrogen?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.789901

Estrogen signaling through the transmembrane G protein-coupled receptor GPR30.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.789901

The ins and outs of GPR30: a transmembrane estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.789901

A transmembrane intracellular estrogen receptor mediates rapid cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.789901

Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.789901

The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17beta-estradiol and hydroxytamoxifen in endometrial cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.789901

Role of GPR30 in endometrial pathology after tamoxifen for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.789901

Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.789901

Epidermal growth factor receptor (EGFR) transactivation by estrogen via the G-protein-coupled receptor, GPR30: a novel signaling pathway with potential significance for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.789901

G protein-coupled receptor 30 is critical for a progestin-induced growth inhibition in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.789901

The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.789901

GPR30 activation opposes estrogen-dependent uterine growth via inhibition of stromal ERK1/2 and estrogen receptor alpha (ERα) phosphorylation signals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.789901

GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.789901

G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.789901

Progestin and G protein-coupled receptor 30 inhibit mitogen-activated protein kinase activity in MCF-7 breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.789901

Activation of GPR30 inhibits the growth of prostate cancer cells through sustained activation of Erk1/2, c-jun/c-fos-dependent upregulation of p21, and induction of G(2) cell-cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357907.2013.789901

10.3109/07357907.2013.789901

21 January 2018

Identifiers

DOI

1 reference

19 December 2017

PubMed ID

23688258

1 reference

19 December 2017